Work

Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

Year: 2018

Type: article

Abstract: Background: The role of neoadjuvant-chemotherapy (NADJ) in cholangiocarcinoma is unknown. The purpose of this study is to evaluate whether NADJ improves overall survival (OS) in cholangiocarcinoma compared to adjuvant-chemotherapy (ADJ).

Source: Annals of Oncology

DOI: 10.1093/annonc/mdy282.146

Authors: S. Yadav, H. Xie, I.B. Riaz, P. Sharma, A. Mahipal, R. McWilliams

Institutions: Mayo Clinic, Bridgeport Hospital, Yale New Haven Health System

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,080

OpenAlex ID: W2898247220

FWCI: 1.57

Cites:

Cited by: 12

Related to: 10